In line with these findings, ULBP2-aCEA BiKE promotes the recognition and lysis of CEA+ tumor cells by the NK cells through NKG2D-ULBP2 interaction, and the efficiency against colon cancer was verified using animal models [87]. Here, ULBP2 is linked to malignant colon neoplasm.